HUM — Humana Inc.
Is HUM overbought or oversold? Here is the current MarketMoodz read.
Humana Inc. (HUM) currently reads Neutral on the MarketMoodz overbought/oversold meter, as of July 5, 2026. The Healthcare name (Healthcare Plans) last closed at $396.75. The rating moved from Overbought to Neutral on July 3, 2026 and has changed 12 times in the last 90 days.
- Public ratingNeutral (as of July 5, 2026)
- Last close$396.75
- Rating changesRating changed 12 times in the last 90 days
- Last changeMoved from Overbought to Neutral on July 3, 2026
- SectorHealthcare
- IndustryHealthcare Plans
Latest MarketMoodz coverage
- Humana Tops Overbought List as Healthcare Outperforms Tech2026-06-13
- Cisco Hits RSI 90 — Most Overbought S&P 500 Stock2026-05-16
- CMS Finalizes 2.48% Medicare Advantage Hike for 2027, Lifts Insurer Stocks2026-04-07
- Levi's Earnings in Focus as Retail and Macro Catalysts Converge2026-04-06
- Trump administration finalizes 2.48% 2027 Medicare Advantage rate; insurers rally2026-04-06
See today's live rating, score and targets
Members see the live hourly rating for HUM — the numeric AI score plus targets and entry zones — while this public page updates nightly.
Start the 14-day trialThis page is for informational purposes only and is not investment, financial, tax, or legal advice. Ratings and research outputs can be wrong, incomplete, or stale. Past performance does not guarantee future results. Always do your own research and consider consulting a qualified professional.
MarketMoodz